[
    [
        {
            "time": "2021-03-05",
            "original_text": "通化东宝：牵手药明康德 强势进军创新药领域",
            "features": {
                "keywords": [
                    "通化东宝",
                    "药明康德",
                    "创新药",
                    "战略合作"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "通化东宝：牵手药明康德 强势进军创新药领域",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "药明康德(02359-HK)去年盈利增59.62%",
            "features": {
                "keywords": [
                    "药明康德",
                    "盈利增长",
                    "59.62%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(02359-HK)去年盈利增59.62%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "药明康德业绩快报：2020年度净利润29.6亿元 同比增长59.62%",
            "features": {
                "keywords": [
                    "药明康德",
                    "业绩快报",
                    "净利润",
                    "29.6亿元",
                    "同比增长",
                    "59.62%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德业绩快报：2020年度净利润29.6亿元 同比增长59.62%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "通化东宝(600867.SH)与上海药明康德就糖尿病等疾病治疗领域达成战略合作",
            "features": {
                "keywords": [
                    "通化东宝",
                    "药明康德",
                    "糖尿病",
                    "战略合作"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "通化东宝(600867.SH)与上海药明康德就糖尿病等疾病治疗领域达成战略合作",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "北向资金今日小幅净买入5.27亿元，贵州茅台连续7日净卖出",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "贵州茅台",
                    "净卖出"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "食品饮料"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日小幅净买入5.27亿元，贵州茅台连续7日净卖出",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "医药生物行业：第四批集采落地 建议上游原料药行业",
            "features": {
                "keywords": [
                    "医药生物",
                    "第四批集采",
                    "原料药"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业：第四批集采落地 建议上游原料药行业",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-05",
            "original_text": "【异动股】药明康德(02359-HK)跌4.52%",
            "features": {
                "keywords": [
                    "药明康德",
                    "异动股",
                    "下跌",
                    "4.52%"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【异动股】药明康德(02359-HK)跌4.52%",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]